Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
A low serum albumin level may suggest liver disease, kidney disease, malnutrition, or chronic inflammatory conditions.
Yes, certain medications and supplements can influence serum albumin levels. It’s important to inform your healthcare provider about all medications you are taking.
No, fasting is generally not required for this test unless specified by your healthcare provider.
The frequency of testing depends on your health condition. Your healthcare provider will recommend the appropriate schedule for monitoring.
Abnormal levels may indicate underlying health issues. Further evaluation and treatment may be needed based on your test results.
The PT Test measures the time it takes for blood to clot, helping diagnose bleeding disorders and monitor anticoagulant therapy.
No, fasting is not required. However, inform your doctor about any medications you are taking.
Results are typically available within a few hours to 24 hours.
It ensures that the dosage of anticoagulant medication is within the therapeutic range to prevent bleeding or clotting complications.
Yes, it can help evaluate liver function and detect liver-related clotting factor deficiencies.
The Anti-dsDNA Antibody Test detects antibodies against double-stranded DNA, which are commonly associated with autoimmune diseases like Systemic Lupus Erythematosus (SLE).
This test is used to diagnose SLE, monitor disease activity, assess treatment response, and differentiate between autoimmune diseases.
No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or health conditions.
Results are typically available within 1 to 2 days after the test.
A positive result suggests the presence of antibodies associated with autoimmune activity, particularly in Systemic Lupus Erythematosus (SLE). Further evaluation is often required to confirm the diagnosis and assess disease activity.